Did you know that eczema was recently discovered to be an immune disorder by researches at the Icahn School of Medicine at Mount Sinai?   In the study, researchers found that the drug Dupilumab, a monoclonal antibody treatment that blocks the action of two key signaling proteins, interleukin (IL)-4 and -13, was able to reverse the skin disease in…